Kevin Cottrell

Kevin Cottrell has a wealth of experience in medicinal chemistry, starting with their early roles as a chemist at DuPont and AstraZeneca Pharmaceuticals. Kevin later joined Vertex Pharmaceuticals, where Kevin held various research positions before eventually becoming an Executive Director at Tango Therapeutics. Their expertise spans across different aspects of medicinal chemistry, making him a valuable asset in the pharmaceutical industry.